January 31, 2002
Chiron Corporation and Global Alliance for TB Drug Development Agree on License of PA-824 Compound for New Tuberculosis Therapeutics
January 19, 2002
Pharmaceutical Firms Battle Against Time to Make New TB Drug
January 14, 2002
Leading Indian Pharma Companies Keen to Participate in Development of Molecule for Drug-Resistant TB by 2010
January 13, 2002
TB Alliance Debuts in India
December 31, 2001
TB Market - Critical and Profitable
December 31, 2001
Tuberculosis: A Continuing, Deadly Threat
December 15, 2001
Report Encourages New TB Drug Development For $700 Million Market
November 30, 2001
Report: TB Drug Market Mostly in Private Hands
November 22, 2001